10-Q: HealthEquity Q3 Net Income Soars 806% on Revenue Growth

HealthEquity, Inc. reported a significant 806% increase in net income for the third quarter ended October 31, 2025, driven by robust custodial revenue growth and reduced operating expenses.

Summary

• Net income for the three months ended October 31, 2025, surged by 806% to $51.7 million, up from $5.7 million in the prior year period.
• Total revenue increased by 7% to $322.2 million for the quarter, with custodial revenue leading the growth at 13% to $159.1 million.
• For the nine months ended October 31, 2025, net income rose 135% to $165.5 million, and total revenue grew 10% to $978.8 million.
• Total operating expenses decreased by 16% for the quarter and 7% for the nine months, primarily due to the absence of a non-recurring lease settlement expense from the prior year.
• HSA Assets grew 15% year-over-year to $34.4 billion, comprising $16.9 billion in cash and $17.5 billion in investments.
• Total Accounts reached 17.3 million, a 5% increase year-over-year, including 10.1 million HSAs and 7.2 million complementary CDBs.
• Adjusted EBITDA increased by 20% for the quarter to $141.8 million and 19% for the nine months to $433.1 million.
• The company repurchased $93.7 million of common stock during the quarter and $219.9 million year-to-date, with $258.8 million remaining authorized.
• The One Big Beautiful Bill Act (OBBBA) is expected to significantly reduce corporate income tax payments for fiscal years ending January 31, 2026, and January 31, 2027.

Sentiment

Score: 8

Explanation: Strong financial performance with significant increases in net income and Adjusted EBITDA, driven by revenue growth and cost efficiencies. The growth in HSA Assets and Total Accounts indicates healthy business expansion. While there are ongoing legal risks, the financial results are robust, and the company is actively managing its capital through debt reduction and share repurchases. The positive impact of the OBBBA on future tax payments is also a favorable development.

Positives

• Net income for the three months ended October 31, 2025, increased by 806% to $51.7 million compared to $5.7 million in the prior year.
• Net income for the nine months ended October 31, 2025, increased by 135% to $165.5 million compared to $70.3 million in the prior year.
• Total revenue grew 7% for the quarter to $322.2 million and 10% for the nine months to $978.8 million.
• Custodial revenue increased by 13% for the quarter and 18% for the nine months, driven by higher average annualized yield on HSA cash (3.53% in Q3 2025 vs 3.17% in Q3 2024) and increased average daily HSA cash.
• Total operating expenses decreased by 16% for the quarter and 7% for the nine months, largely due to the absence of a non-recurring lease settlement expense from the prior year.
• Income from operations significantly increased to $78.7 million for the quarter (from $19.6 million) and $251.4 million for the nine months (from $120.2 million).
• HSA Assets grew 15% year-over-year to $34.4 billion, with HSA investments increasing 29% to $17.5 billion.
• Total Accounts increased 5% year-over-year to 17.3 million.
• Adjusted EBITDA increased by 20% for the quarter to $141.8 million and 19% for the nine months to $433.1 million.
• Interest expense decreased by 23% for the quarter and 3% for the nine months due to lower average interest rates and principal balance on borrowings.
• The company prepaid $75.0 million on its credit agreement during the nine months ended October 31, 2025.
• The One Big Beautiful Bill Act (OBBBA) is expected to significantly reduce corporate income tax payments for fiscal years ending January 31, 2026, and January 31, 2027.
• The company is in compliance with all covenants under its Credit Agreement.

Negatives

• New HSAs from sales decreased by 14% year-to-date to 487,000 compared to 568,000 in the prior year.
• Service revenue growth was modest at 1% for both the three and nine months, partially offset by lower average service fees per account.
• Interest income on corporate cash decreased, contributing to a $1.9 million decrease in other income, net, for the quarter.
• The effective income tax rate increased significantly to 23.5% for the three months ended October 31, 2025, compared to 8.3% in the prior year, primarily due to increased pre-tax income and lower R&D tax credits.
• Custodial costs increased by 6% for the quarter and 11% for the nine months, driven by higher average daily HSA cash and an increase in the average annualized rate of interest retained by HSA members.

Risks

• Subject to multiple legal actions, including a consolidated putative class action lawsuit and a mass arbitration action, related to a cybersecurity incident in fiscal 2025 where a business partner's user account containing personally identifiable information was breached.
• Regulatory inquiries related to the cybersecurity incident are ongoing.
• The amount of potential loss associated with these lawsuits and regulatory actions cannot be reasonably estimated, and an unfavorable outcome could have a material adverse impact on financial position, results of operations, and cash flows.
• Future performance is subject to risks related to the ability to successfully integrate acquired businesses and HSA portfolios.
• Changes in U.S. health insurance structure and healthcare policy (e.g., 'Medicare for all' plans) could materially and adversely affect the business.
• Changes in U.S. tax law and regulations, which are speculative, could affect the business as offerings are enabled or advantaged by these provisions.
• Competition from direct competitors (e.g., Fidelity Investments, UnitedHealth Group's Optum, Webster Bank) and indirect competitors, some of whom have more resources.
• Exposure to short-term fluctuations and sustained shifts in prevailing interest rates, which affect custodial revenue and interest expense on variable-rate debt.
• Reliance on cash and cash equivalents in bank and other depository accounts that frequently exceed federally insured limits, posing concentration of credit risk.
• Inflationary factors may adversely affect operating results if revenue does not correspondingly increase.

Future Outlook

The company anticipates continued increases in service, custodial, and interchange revenue, driven by growth in Total Accounts, HSA investments, and higher average annualized yields on HSA cash as existing agreements renew. Service costs are expected to decrease due to technology investments and operational efficiencies, while technology and development expenses will increase with ongoing modernization efforts. Sales and marketing expenses are projected to rise due to brand awareness and engagement programs, particularly targeting newly HSA-eligible individuals. Merger integration expenses are expected to continue decreasing as activities conclude. The One Big Beautiful Bill Act is forecasted to significantly reduce corporate income tax payments for fiscal years 2026 and 2027, though the overall tax expense and effective rate are not expected to materially change. The company believes its current liquidity is sufficient for the next 12 months but may seek additional financing if needed for future business activities.

Management Comments

• We believe that continued growth in healthcare costs and related factors will spur continued growth in HSA-qualified health plans and HSAs and may encourage additional policy changes making HSAs or similar vehicles available to new populations such as individuals in Medicare.
• We believe that increased participation in our Enhanced Rates offering, diversification of Depository Partners and insurance company partners, varied contract terms, and other factors reduce our exposure to short-term fluctuations in prevailing interest rates and mitigate the short-term impact of sustained increases or declines in prevailing interest rates on our custodial revenue.
• We believe that innovations incorporated in our technology differentiate us from our competitors and help drive our growth by enabling us to better assist consumers to make healthcare saving and spending decisions and maximize the value of their tax-advantaged benefits.
• Our Purple culture, which we believe is a significant factor in our ability to attract and retain customers and to address opportunities in the rapidly changing healthcare sector.
• We believe our existing cash, cash equivalents, and revolving credit facility will be sufficient to meet our operating and capital expenditure requirements for at least the next 12 months.

Industry Context

HealthEquity operates within a dynamic U.S. healthcare landscape characterized by rising employer-sponsored health insurance premiums (up 24% since 2019, 52% since 2014), which drives increased participation in HSA-qualified health plans. Recent legislative changes, such as the One Big Beautiful Bill Act, further expand HSA eligibility and services, creating a larger addressable market. The company is a leader in HSA administration, holding the largest number of accounts and second-largest HSA Assets, positioning it well to capitalize on these trends. However, the industry faces potential disruptions from policy changes like 'Medicare for all' and intense competition from major financial institutions (e.g., Fidelity) and healthcare service giants (e.g., Optum), necessitating continuous innovation and strategic acquisitions.

Comparison to Industry Standards

• HealthEquity is the largest HSA provider by number of accounts and the second largest by HSA Assets as of June 2025, according to the 2025 Midyear Devenir HSA Research Report, indicating a strong competitive position.
• The company's market share of HSA Assets has grown from 4% in December 2010 to 20% as of June 2025, demonstrating significant growth relative to the overall HSA market.
• The company's product breadth, offering an integrated suite of HSAs and complementary CDBs, aligns with the preference of the vast majority of employers for a single partner, as per Aite Group research.
• The company's use of Treasury bond forwards to hedge interest rate risk is a standard financial practice to mitigate market volatility, similar to strategies employed by other financial institutions managing large cash portfolios.
• Competitors like Fidelity Investments, UnitedHealth Group's Optum, and Webster Bank are noted, suggesting HealthEquity operates in a competitive environment with well-resourced players.

Corporate Governance

Legal Proceedings

• Subject to multiple legal actions, including a consolidated putative class action lawsuit in federal court in the District of Utah and a mass arbitration action, related to a cybersecurity incident in fiscal 2025.
• Plaintiffs allege failure to implement reasonable data security practices, resulting in a breach and disclosure of personally identifiable information and protected health information.
• Plaintiffs are seeking unspecified monetary damages, equitable relief, costs, and attorneys' fees.
• A court order granted consolidation of class action lawsuits on August 22, 2024, and an amended complaint was filed on October 15, 2024.
• The company's motion to dismiss and motion to compel arbitration were dismissed without prejudice on May 5, 2025, with the court noting refiling is possible after discovery.
• Several regulatory inquiries related to the cybersecurity incident are ongoing.
• The amount of potential loss cannot be reasonably estimated, and no loss accrual has been recorded as it is not deemed probable or estimable, but an unfavorable outcome could have a material adverse impact.

Stakeholder Impact

• Shareholders: Positive impact from increased net income, Adjusted EBITDA, and ongoing stock repurchase programs. Potential future dilution from equity incentive plans. Risk from cybersecurity legal proceedings and potential adverse outcomes.
• Employees: Impacted by stock-based compensation plans. Potential for career development and advancement opportunities as the company invests in human capital.
• Customers (Members/Clients): Benefit from technology investments aimed at improving self-service capabilities, transaction processing, and access to healthcare solutions. Potential risk of data breach from cybersecurity incidents.
• Depository/Insurance Partners: Continued contractual relationships for holding HSA cash, with terms impacted by prevailing interest rates.
• Regulatory Authorities: Ongoing engagement due to regulatory inquiries related to the cybersecurity incident and compliance with various federal and state laws.

Next Steps

• Continue evaluating and integrating acquired HSA portfolios and businesses, including ongoing integration activities for the Further acquisition.
• Invest in the modernization and security of proprietary technology platforms, including architecture, infrastructure, transaction processing, data-driven engagement, AI tools (Expedited Claims and HSAnswers), chip-enabled cards, and mobile wallet.
• Focus on brand awareness and Client and member engagement programs, including campaigns for newly HSA-eligible individuals under recent legislative expansion.
• Complete remaining merger integration activities.
• Monitor and react to legal and regulatory trends, including state privacy regulations and ongoing cybersecurity-related legal proceedings.
• Manage the repricing of HSA cash agreements with Depository Partners and insurance company partners, aiming for higher yields and increased participation in the Enhanced Rates offering.
• Continue common stock repurchases under the authorized program.

Key Dates

Recommendation

The company demonstrated exceptional financial performance with an 806% increase in Q3 net income and a 135% increase year-to-date, driven by robust revenue growth across all segments, particularly custodial revenue benefiting from higher interest rates. Operating expenses were well-managed, leading to significant improvements in profitability and Adjusted EBITDA. The continued growth in HSA Assets and Total Accounts, coupled with strategic technology investments and the positive impact of the One Big Beautiful Bill Act on future tax payments, indicates strong underlying business momentum and a favorable outlook. While legal risks from the cybersecurity incident exist, the company's strong financial position, active capital management through share repurchases, and compliance with debt covenants suggest a compelling investment opportunity.

Keywords

HealthEquity, HQY, SEC Filing, 10-Q, Quarterly Report, Financial Results, HSA, Health Savings Accounts, CDB, Consumer-Directed Benefits, Custodial Revenue, Interchange Revenue, Service Revenue, Net Income, Adjusted EBITDA, HSA Assets, Stock Repurchase, Cybersecurity Incident, Legal Proceedings, Interest Rates, Tax Law, OBBBA, Healthcare Technology, Financial Services